Expectations for one of the leaders in investments in the biotech sector – pdf
BB Biotech is an investment firm specializing in the acquisition of stakes in biotechnology companies. Developments in this area could bring important benefits to investors. Expectations for one of the leaders in investments in the biotechnology sector.
At present, between 5% and 8% of the world’s population is affected by pathologies
Biotechnology and autoimmune diseases
Autoimmune diseases are among those most studied in the biotechnology sector. The importance of these diseases is decreed by the numbers recorded throughout the world. Medical research currently knows over 100 of these diseases, which can affect the nervous system, organs and muscle tissue. At present, between 5% and 8% of the world’s population is affected by these pathologies.
Researchso, it proceeds very quickly and the results obtained are quickly transformed into profits for the companies. BB Biotech is heavily exposed in this sector and could derive important benefits from it in the coming years. Therefore, what was written a few months ago is confirmed, namely that BB Biotech shares focus on dividend yield and growth prospects.
Just think that one of BB Biotech’s largest holdings reported an approximately 80% increase in revenue in the last quarter of 2022.
At present, according to the recommendations of analysts, the stock is undervalued by about 25%.
Expectations for one of the leaders in investments in the biotechnology sector: the indications of the graphic analysis
The title BB Biotech (MIL:BB) reached a final price on January 2nd at €56.9, up 0.71% on the previous session.
From 2009 to today, BB Biotech stock has closed the year with a loss only twice. 2022 was one of them and it was also the one with the biggest loss from 2002 onwards.
It should therefore come as no surprise that averages are set low. However, the last three sessions have shown signs of stability and could herald an imminent bullish reversal. On the other hand also the averages are closing in, increasing the likelihood of a reversal.
It should also be noted that in the case of a continuation of the decline, for the 53 euro area there is a support that held throughout 2022. This level, therefore, could be an excellent springboard for a relaunch in the event of a continuation of the decline.
